Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study
Nicola Potere, Marcello Di Nisio, Donatella Concetta Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti
Topics & Concepts
MedicineTocilizumabHypoxemiaPneumoniaNeutropeniaMechanical ventilationInternal medicineGastroenterologyRheumatoid arthritisToxicityCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and Mechanisms